BGI Genomics, the world’s leading provider of genomic sequencing and proteomic services, serves customers in over 100 countries. They work with academic institutions, pharmaceutical companies, healthcare providers, and other organizations. BGI needed branding for their new product "COLOTECT," a multi-target fecal DNA test for detecting colorectal cancer and advanced precancerous lesions. Their expectations included a cohesive and professional brand image that highlights the test's advanced capabilities and reliability.

For BGI, we developed the branding for "COLOTECT," including a complete design guideline and illustrations for the test kit. Our approach was to ensure the branding conveyed the precision and innovation behind the product. We focused on creating a clear, professional, and approachable design that resonates with both healthcare providers and patients, emphasizing the product's effectiveness and BGI's expertise in genomic solutions.